Encompass Health Corporation
Encompass Health Corporation (EHC) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
ehc · stock forecast · 26 analysts (3M) · FMP · updated Jun 8, 2026
Analyst Rating & Consensus
Based on 26 Wall Street analysts in the past 3 months
Buy
26 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$152
Consensus
$146
+40.4% upside
Low
$140
Median: $146 · Last Close: $104.01
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Consensus Target
$146.00
40.4% upside
High Target
$152
46.1%
Low Target
$140
34.6%
Current Price
$104.01
as of today
Based on analyst price targets, the EHC stock price prediction for the next 12 months ranges from $140 to $152. The consensus EHC price forecast of $146.00 implies 40.4% upside from the current price of $104.01.
Short-Term Price Prediction
Algorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $102.24 | ↓ 1.70% |
1-day model range: $101.84–$102.64. Peak: $102.64 (-1.70%).
Long-Term Stock Price Prediction
Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $125 | +20.0% |
| 2028 | $141 | +35.5% |
| 2029 | $153 | +46.9% |
| 2030 | $161 | +55.0% |
| 2031 | — | +60.5% |
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
NEUTRAL
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · EHC · Jun 8, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-05-05 | Barclays | Maintains | Overweight→Overweight |
| 2026-02-06 | Barclays | Maintains | Overweight→Overweight |
| 2025-10-30 | Barclays | Maintains | Overweight→Overweight |
| 2025-10-02 | UBS | Maintains | Buy→Buy |
| 2025-09-16 | Keybanc | Maintains | Overweight→Overweight |
| 2025-09-10 | B of A Securities | Maintains | Buy→Buy |
| 2025-08-14 | Truist Securities | Maintains | Buy→Buy |
| 2025-08-06 | UBS | Maintains | Buy→Buy |
| 2025-06-05 | Stephens & Co. | Maintains | Overweight→Overweight |
| 2025-05-27 | Keybanc | Maintains | Overweight→Overweight |
Wall Street analysts have recently issued updated ratings on Encompass Health Corporation (EHC) stock. Of the recent 162 rating actions, 8 were upgrades and 9 were downgrades. 26 analysts currently cover EHC.
Analyst Recommendation Trends
EHC analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 1 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$6.4B
↓ 14.4% YoY
Revenue Next Year
$6.9B
↑ 8.1% YoY
EPS This Year
$6.01
EPS Next Year
$6.54
↑ 8.8% YoY
EPS ForecastReported vs Estimated
Analysts forecast EHC EPS of $6.01 for the current fiscal year, based on estimates from 8 analysts. The EHC revenue forecast is $6.4B for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The EHC stock forecast is supported by two independent data sources: analyst consensus ratings from 26 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus EHC price target is $146.00 (+40.4% upside), with an analyst consensus of Buy.
The EHC short-term stock prediction for tomorrow is $102.24 (-1.70%). The EHC stock price prediction for 2027 estimates an average of $125. The EHC stock prediction for 2030 projects a range of $154–$168.
Encompass Health Corporation trades on NYSE under the ticker EHC. The EHC stock outlook for 2027 is broadly positive, supported by a Buy consensus among 81% of covering analysts.
Frequently asked questions
EHC forecast · 8 questionsAccording to 26 Wall Street analysts, the average 12-month EHC price target is $146.00, with a high forecast of $152.00 and a low of $140.00. The median price target is shown in the chart above when available. This implies +40.4% potential upside from the current price of $104.01.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.